Missed Dell’s 248% Run? IGPT Keeps Riding the AI Wave Higher
Dell Technologies surged 248% from year-end 2025 to midsummer 2026, sparking a parallel rally in the IGPT AI ETF. Thi...
What To Know Before Getting A Cash Advance
Before getting a cash advance, it's crucial to know the key factors involved. We provide insights to help you make informed decisions.
22,697 articles
State Trap: Where the Same Retirement Portfolio Costs More
Two retirees with identical $1.5 million portfolios may see thousands more in annual costs simply because they live i...
Dementia Retirement’s Most Expensive Bill Hits Medicare Gap
A dementia diagnosis reshapes retirement plans as custodial care bills far exceed medical costs and Medicare coverage...
CoreWeave's Sold Company Shares: What It Means for Investors
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
This Investment Platform Lets Investors Build AI Indices
NovaIndex introduces AI-powered index construction from a single prompt, with an uncapped 1% transfer match for new m...
Alysa Makes History First: US Champion Since 2002 in Skating
Alysa Liu’s historic win isn’t just a sports milestone—it's a finance case study for athletes. This piece breaks down...
Nvidia’s Earnings Report Just a Prelude to March GTC Bets
Nvidia’s latest earnings release produced solid numbers, but traders say the real move will come from the March GTC. ...
Bitcoin’s Self Custody Culture Sparks Inheritance Risk
A growing share of crypto wealth sits behind private keys. With no centralized backstop, 2026 could reveal the first ...
2 High-Flying Stocks with More Upside to Buy and Hold
Two high-flying stocks with more upside may fit a patient investor's long-term plan. This article dives into NVIDIA a...
What Target's Michael Fiddelke Means for Investors Now
Target unveiled a bold turnaround, but questions linger about what Target's Michael Fiddelke may be missing about eve...
NANC Investors Have 45-Day Blind Spot as Rates Rise
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...
Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status